International Stem Cell Corporation Announces Positive Interim Clinical Results For Parkinson’s Disease Clinical Trial – Clinical Leader
|
International Stem Cell Corporation Announces Positive Interim Clinical Results For Parkinson's Disease Clinical Trial
Clinical Leader Carlsbad CA (GLOBE NEWSWIRE) – International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today the positive six months … |
